Most just lately, it has been identified that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to some big selection of endogenous opioids. As opposed to most opioid receptors, this receptor functions as a scavenger and would not act